HOME   |    PDF   |   


Molecular docking analysis of alkaloid compounds with beta-catenin towards the treatment of colon cancer



Rajagopal Ponnulakshmi1, Veeraraghavan Vishnupriya2, Surapaneni Krishna Mohan3, Srinivasan
Abilasha4, Govindan Ramajayam5, Periyasamy Vijayalakshmi6, Manikkam Rajalakshmi6, Jayaraman Selvaraj2*



1Central Research Laboratory, Meenakshi Academy of Higher Education and Research (Deemed to be University), Chennai-600 078, India; 2Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai - 600 077, India; 3Department of Biochemistry, Panimalar Medical College Hospital & Research Institute, Varadharajapuram, Poonamallee, Chennai-600 123, Chennai, Tamil Nadu, India 4Department of Anatomy, Asan Memorial Dental College & Hospital, Asan Nagar, Chengalpattu, Tamil Nadu, India; 5Multi Disciplinary Research Unit, Madurai Medical College, TamilNadu, India; 6DBT-BIF Centre, PG & Research Department of Biotechnology & Bioinformatics, Holy Cross College (Autonomous), Trichy, Tamil Nadu, India;



Dr. Jayaraman Selvaraj - E-mail: jselvaendo@gmail.com; *Corresponding author:


Article Type

Research Article



Received February 15, 2019; Revised March 10, 2020, Accepted March 18, 2020; Published March 31, 2020



It is known that beta-catenin is associated with fibromatosis, sarcoma and mesenchymal tumor. Therefore, it is of interest to design an effective inhibtitor to the target protein beta-catenin. In this study, we report the molecular docking analysis of alkaloid compounds (aristolochicacid, cryptopleurine, demecolcine, fagaronine and thalicarpine) with beta-catenin for further consideration towards the design and development of potential inhintors for the treatmnet of colon cancer.



Colon cancer, β-catenin, Molecular docking, ADME



Ponnulakshmi et al. 16(3): 283-287 (2020)


Edited by

P Kangueane






Biomedical Informatics



This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.